CAS No.
[1405-87-4 (Unlabeled)]
Storage Condition
Refer MSDS for complete information
Synonyms
L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-α-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-, (10→4)-lactam-D7
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Baciim-d7 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Baciim-d7 usage and description
Bacitracin A-d7 is an isotopically labeled form of Bacitracin, an antibiotic peptide that is commonly used to treat bacterial infections. Bacitracin A-d7 is labeled with seven deuterium atoms, which can be used for quantitative analysis and pharmacokinetic studies.
Bacitracin A-d7 works by inhibiting the synthesis of bacterial cell walls, which leads to the death of the bacteria. It is particularly effective against gram-positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes.
Bacitracin A-d7 is typically administered topically, although it can also be given orally in certain cases. It is commonly used to treat skin infections, such as impetigo and cellulitis, as well as eye infections such as conjunctivitis.
Chemically, Bacitracin A-d7 is a cyclic peptide composed of 13 amino acids. It is synthesized by the bacterium Bacillus subtilis, which is commonly found in soil. Bacitracin A-d7 is a relatively stable molecule, but it can be degraded by heat, acid, and enzymes.
Overall, Bacitracin A-d7 is an important tool for researchers studying the pharmacokinetics and efficacy of Bacitracin, as well as for clinicians treating bacterial infections.
